Ectopic expression of B7-1 (CD80) on T lymphocytes in autoimmune lpr and gld mice

Clinical Immunology

Volumn 91, Issue 3, 1999, Pages 302-309

  Weintraub, Jory P ^a   Cohen, Philip L ^a  

^a NONE

Author keywords

Autoimmunity; B7 1 (CD80); Costimulation; gld; T cells

Indexed keywords

B7 ANTIGEN; FAS ANTIGEN;

ANIMAL CELL; APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; FLOW CYTOMETRY; GENE MUTATION; IMMUNOFLUORESCENCE; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE;

EID: 0033005540     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1006/clim.1999.4717     Document Type: Article

References (52)

1. Wallach D. Apoptosis. Placing death under control [news; comment]. Nature. 388:1997;123-126.
2. Abastado J. P. Apoptosis: Function and regulation of cell death [Review] [72 refs]. Res. Immunol. 147:1996;443-456.
3. Nagata S. Apoptosis by death factor [Review] [85 refs]. Cell. 88:1997;355-365.
4. Mountz J. D., Zhou T., Wu J., Wang W., Su X., Cheng J. Regulation of apoptosis in immune cells [Review] [1168 refs]. J. Clin. Immunol. 15:1995;1-16.
5. Cohen, P. L. Eisenberg, R. A. The lpr and gld genes in systemic autoimmunity: Life and death in the Fas lane, Immunol. Today, 14, 97, 1993, 13, 427, 428, 1992.
6. Cohen, P. L. Eisenberg, R. A. The lpr and gld genes in systemic autoimmunity: Life and death in the Fas lane, Immunol. Today, 14, 97, 1993, 13, 427, 428, 1992.
7. Cohen P. L., Eisenberg R. A. Lpr and gld: Single gene models of systemic autoimmunity and lymphoproliferative disease [Review] [207 refs]. Annu. Rev. Immunol. 9:1991;243-269.
8. Nagata S., Golstein P. The Fas death factor [Review] [98 refs]. Science. 267:1995;1449-1456.
9. Nagata S. Mutations in the Fas antigen gene in lpr mice [Review] [45 refs]. Semin. Immunol. 6:1994;3-8.
10. Watanabe-Fukunaga R., Brannan C. I., Copeland N. G., Jenkins N. A., Nagata S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature. 356:1992;314-317.
11. Suda T., Takahashi T., Golstein P., Nagata S. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell. 75:1993;1169-1178.
12. Suda T., Nagata S. Purification and characterization of the Fas-ligand that induces apoptosis. J. Exp. Med. 179:1994;873-879.
13. Takahashi T., Tanaka M., Brannan C. I., Jenkins N. A., Copeland N. G., Suda T., Nagata S. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell. 76:1994;969-976.
14. Tanaka M., Suda T., Takahashi T., Nagata S. Expression of the functional soluble form of human fas ligand in activated lymphocytes. EMBO J. 14:1995;1129-1135.
15. Nagata S. Fas and Fas ligand: a death factor and its receptor [Review] [74 refs]. Adv. Immunol. 57:1994;129-144.
16. Alderson M. R., Tough T. W., Braddy S., Davis-Smith T., Roux E., Schooley K., Miller R. E., Lynch D. H. Regulation of apoptosis and T cell activation by Fas-specific mAb. Int. Immunol. 6:1994;1799-1806.
17. Ogasawara J., Watanabe-Fukunaga R., Adachi M., Matsuzawa A., Kasugai T., Kitamura Y., Itoh N., Suda T., Nagata S. Lethal effect of the anti-Fas antibody in mice. Nature. 365:1993;568.
18. Nagata S., Suda T. Fas and Fas ligand: lpr and gld mutations [Review] [46 refs]. Immunol. Today. 16:1995;39-43.
19. Singer G. G., Carrera A. C., Marshak-Rothstein A., Martinez C., Abbas A. K. Apoptosis, Fas and systemic autoimmunity: the MRL-lpr/lpr model [Review] [66 refs]. Curr. Opin. Immunol. 6:1994;913-920.
20. Morse H. C. III, Davidson W. F., Yetter R. A., Murphy E. D., Roths J. B., Coffman R. L. Abnormalities induced by the mutant gene lpr: expansion of a unique lymphocyte subset. J. Immunol. 129:1982;2612-2615.
21. Sobel E. S., Kakkanaiah V. N., Rapoport R. G., Eisenberg R. A., Cohen P. L. The abnormal lpr double-negative T cell fails to proliferatein vivo. Clin. Immunol. Immunopathol. 74:1995;177-184.
22. Giese T., Davidson W. F. Evidence for early onset, polyclonal activation of T cell subsets in mice homozygous for lpr. J. Immunol. 149:1992;3097-3106.
23. Budd R. C., Schumacher J. H., Winslow G., Mosmann T. R. Elevated production of interferon-gamma and interleukin 4 by mature T cells from autoimmune lpr mice correlates with Pgp-1 (CD44) expression. Eur. J. Immunol. 21:1991;1081-1084.
24. Sobel E. S., Yokoyama W. M., Shevach E. M., Eisenberg R. A., Cohen P. L. Aberrant expression of the very early activation antigen on MRL/Mp-lpr/lpr lymphocytes. J. Immunol. 150:1993;673-682.
25. Watanabe D., Suda T., Hashimoto H., Nagata S. Constitutive activation of the Fas ligand gene in mouse lymphoproliferative disorders. EMBO J. 14:1995;12-18.
26. Chu J. L., Ramos P., Rosendorff A., Nikolic-Zugic J., Lacy E., Matsuzawa A., Elkon K. B. Massive upregulation of the Fas ligand in lpr and gld mice: Implications for Fas regulation and the graft-versus-host disease-like wasting syndrome. J. Exp. Med. 181:1995;393-398.
27. Monroe J. G., Cambier J. C., Mody E. A., Pisetsky D. S. Hyper-Ia antigen expression on B cells from B6-lpr/lpr mice correlates with manifestations of the autoimmune state. Clin. Immunol. Immunopathol. 34:1985;124-129.
28. Weintraub J. P., Eisenberg R. A., Cohen P. L. Up-regulation of Fas and the costimulatory molecules B7-1 and B7-2 on peripheral lymphocytes in autoimmune B6/gld mice. J. Immunol. 159:1997;4117-4126.
29. Thompson C. B. Distinct roles for the costimulatory ligands B7-1 and B7-2 in T helper cell differentiation? Cell. 81:1995;979-982.
30. June C. H., Bluestone J. A., Nadler L. M., Thompson C. B. The B7 and CD28 receptor families [Review] [93 refs]. Immunol. Today. 15:1994;321-331.
31. Chu J. L., Drappa J., Parnassa A., Elkon K. B. The defect in Fas mRNA expression in MRL/lpr mice is associated with insertion of the retrotransposon, ETn. J. Exp. Med. 178:1993;723-730.
32. Adachi M., Watanabe-Fukunaga R., Nagata S. Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of lpr mice. Proc. Natl. Acad. Sci. USA. 90:1993;1756-1760.
33. Wu J., Zhou T., He J., Mountz J. D. Autoimmune disease in mice due to integration of an endogenous retrovirus in an apoptosis gene. J. Exp. Med. 178:1993;461-468.
34. Linsley P. S. Distinct roles for CD28 and cytotoxic T lymphocyte-associated molecule-4 receptors during T cell activation? J. Exp. Med. 182:1995;289-292.
35. June C. H., Ledbetter J. A., Linsley P. S., Thompson C. B. Role of the CD28 receptor in T-cell activation [Review] [58 refs]. Immunol. Today. 11:1990;211-216.
36. Thompson C. B., Allison J. P. The emerging role of CTLA-4 as an immune attenuator [Review] [40 refs]. Immunity. 7:1997;445-450.
37. Linsley P. S., Brady W., Urnes M., Grosmaire L. S., Damle N. K., Ledbetter J. A. CTLA-4 is a second receptor for the B cell activation antigen B7. J. Exp. Med. 174:1991;561-569.
38. Leung H. T., Linsley P. S. The CD28 costimulatory pathway [Review] [104 refs]. Ther. Immunol. 1:1994;217-228.
39. Giese T., Allison J. P., Davidson W. F. Functionally anergic lpr and gld B220+ T cell receptor (TCR)-alpha/beta+ double-negative T cells express CD28 and respond to costimulation with phorbol myristate acetate and antibodies to CD28 and the TCR. J. Immunol. 151:1993;597-609.
40. Prabhu Das M. R., Zamvil S. S., Borriello F., Weiner H. L., Sharpe A. H., Kuchroo V. K. Reciprocal expression of co-stimulatory molecules, B7-1 and B7-2, on murine T cells following activation. Eur. J. Immunol. 25:1995;207-211.
41. Sansom D. M., Hall N. D. B7/BB1, the ligand for CD28, is expressed on repeatedly activated human T cells in vitro. Eur. J. Immunol. 23:1993;295-298.
42. Azuma M., Yssel H., Phillips J. H., Spits H., Lanier L. L. Functional expression of B7/BB1 on activated T lymphocytes. J. Exp. Med. 177:1993;845-850.
43. Valle A., Garrone P., Yssel H., Bonnefoy J. Y., Freedman A. S., Freeman G., Nadler L. M., Banchereau J. mAb 104, a new monoclonal antibody, recognizes the B7 antigen that is expressed on activated B cells and HTLV-1-transformed T cells. Immunology. 69:1990;531-535.
44. Karandikar N. J., Vanderlugt C. L., Eagar T., Tan L., Bluestone J. A., Miller S. D. Tissue-specific up-regulation of B7-1 expression and function during the course of murine relapsing experimental autoimmune encephalomyelitis. J. Immunol. 161:1998;192-199.
45. Noel P. J., Boise L. H., Green J. M., Thompson C. B. CD28 costimulation prevents cell death during primary T cell activation. J. Immunol. 157:1996;636-642.
46. Boise L. H., Minn A. J., Noel P. J., June C. H., Accavitti M. A., Lindsten T., Thompson C. B. CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL. Immunity. 3:1995;87-98.
47. Walker L. S., McLeod J. D., Boulougouris G., Patel Y. I., Hall N. D., Sansom D. M. Down-regulation of CD28 via Fas (CD95): Influence of CD28 on T-cell apoptosis. Immunology. 94:1998;41-47.
48. Lu L., Qian S., Hershberger P. A., Rudert W. A., Lynch D. H., Thomson A. W. Fas ligand (CD95L) and B7 expression on dendritic cells provide counter-regulatory signals for T cell survival and proliferation. J. Immunol. 158:1997;5676-5684.
49. Lu L., Qian S., Hershberger P., Rudert W. A., Li Y., Chambers F. G., Starzl T. E., Lynch D. H., Thomson A. W. Blocking of the B7-CD28 pathway increases apoptosis induced in activated T cells by in vitro-generated CD95L (FasL) positive dendritic cells. Transplan. Proc. 29:1997;1094-1095.
50. Van Parijs L., Ibraghimov A., Abbas A. K. The roles of costimulation and Fas in T cell apoptosis and peripheral tolerance. Immunity. 4:1996;321-328.
51. Linsley P. S., Greene J. L., Tan P., Bradshaw J., Ledbetter J. A., Anasetti C., Damle N. K. Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes. J. Exp. Med. 176:1992;1595-1604.
52. Finck B. K., Linsley P. S., Wofsy D. Treatment of murine lupus with CTLA4Ig. Science. 265:1994;1225-1227.